A subject participating in the (b)(6) trial (subject id (b)(6)) underwent initial implantation of the maestro rechargeable system on (b)(6) 2011.This subject has had a history of multiple low impedance events related to the implanted posterior lead, resulting in a need to restart therapy.Reported low impedance events for this subject occurred on (b)(6) 2014, (b)(6) 2015, (b)(6) 2016, and a final report of continued impedance issues on (b)(6) 2016.On (b)(6) 2016, it was also reported that this subject is unreliable with charging and attending clinic visits.On april 27, 2017, enteromedics was informed that this subject has decided to have the device explanted.The device was subsequently explanted without incident on (b)(6) 2017.
|